scispace - formally typeset
A

Ayako Fujiwara

Researcher at Osaka University

Publications -  37
Citations -  823

Ayako Fujiwara is an academic researcher from Osaka University. The author has contributed to research in topics: Lung cancer & Survival rate. The author has an hindex of 12, co-authored 36 publications receiving 673 citations.

Papers
More filters
Journal ArticleDOI

IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.

TL;DR: IL‐6 may contribute to maintenance of a paracrine loop that functions as part of the communication between CAFs and NSCLC cells, resulting in chemoresistance.
Journal ArticleDOI

Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.

TL;DR: Adenocarcinoma, tumors located in the upper or middle lobe, tumor size >3 cm, and SUV(max) of primary tumor >4.0 g/ml are risk factors for occult MLN metastasis in patients with NSCLC who were diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT.
Journal ArticleDOI

Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience

TL;DR: Surgical resection of pulmonary metastasis from RCC has a favourable outcome in selected patients, DFI and completeness of resection are prognostic markers for survival after pulmonary metastasectomy and repeat lung resection for metastatic RCC is a safe procedure that provides satisfactory patient outcomes.
Journal ArticleDOI

Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma

TL;DR: In this paper, the outcomes after repeat pulmonary resection for colorectal cancer (CRC) and the factors associated with the prognosis of these patients remain uncharacterized.
Journal ArticleDOI

Brain metastasis from colorectal cancer: prognostic factors and survival.

TL;DR: The median survival for patients with brain metastasis (BM) from colorectal cancer (CRC) is short as mentioned in this paper, and the prognosis of patients with BM from CRC was associated with the curability of the therapy for BM, number of metastatic organs, and the serum CEA level.